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14-3-3 s, a target gene of the p53 tumour suppressor protein, has been shown to regulate the cell cycle at the G2/M checkpoint.
Recent studies have demonstrated that 14-3-3 s is downregulated by hypermethylation of the CpG island in several types of cancer.
In this study, we investigated the expression and methylation status of 14-3-3 s in human salivary gland adenoid cystic carcinoma
(ACC) and mucoepidermoid carcinoma (MEC). Immunohistochemical analysis revealed that the positive expression rate of 14-3-3 s
in ACC (one out of 14) was markedly lower than that in MEC (ten out of 10). Since most of the ACCs carried the wild-type p53
protein, downregulation of 14-3-3 s in ACC may not be due to the dysfunction of p53 pathway. Microdissection–methylation-
specific PCR revealed that frequent hypermethylation of the 14-3-3 s gene was observed in ACC when compared to that in MEC. In
cultured-ACC cells, we confirmed the downregulation of 14-3-3 s via hemimethylation of the gene by sequencing analysis after
sodium bisulphite treatment. Furthermore, re-expression of 14-3-3 s in the ACC cells was induced by the treatment with DNA
demethylating agent, 5-aza-20-deoxycytidine. Irradiation apparently induced the enhanced expression of 14-3-3 s and G2/M arrest in
normal salivary gland cells; however, in the ACC cells, neither induction of 14-3-3 s nor G2/M arrest was induced by irradiation.
These results suggest that downregulation of 14-3-3 s might play critical roles in the neoplastic development and radiosensitivity of
ACC.
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Salivary gland cancers (SGCs) are somewhat rare diseases,
comprising about 10% of the head and neck cancers (Speight
and Barrett, 2002). Estimated annual incidence of this diseases is
approximately 400 cases in Japan (Ajiki et al, 2001); however, it is
well known that prognosis of SGCs is considerably poor
(Bensadoun et al, 2001). Salivary gland cancers are divided
histologically into low-grade and high-grade malignancies (Seifert
and Sobin, 1992). High-grade SGCs, such as adenoid cystic car-
cinoma (ACC) and mucoepidermoid carcinoma (MEC) (Batsakis,
1979), invade the surrounding tissues (including nerve, muscle,
and cutaneous tissue), and frequently metastasise to the regional
lymph nodes and distant organs, such as lungs and brain. Adenoid
cystic carcinoma and MEC, the most common malignancies
of the salivary glands, are clinically and pathologically different.
Adenoid cystic carcinoma occurs frequently in the minor salivary
glands (59% of total malignant tumours in minor salivary gland;
Le et al, 1999). On the other hands, MEC occurs frequently in
the major salivary glands (51% of total malignant tumours in
major salivary gland; Pinkston and Cole, 1999). Although radical
surgery has been the main therapy for these cancers, irradiation
has often been recommended for the treatment of the advanced
SGCs. However, the radiosensitivity is reported to be quite
different in ACC and MEC. Combination radical surgery with
radiotherapy in ACC has led to superior results in many studies
(Simpson et al, 1984; Vikram et al, 1984; Miglianico et al, 1987;
Garden et al, 1995; Parsons et al, 1996), but in MEC such
combination treatment is generally less effective (Nascimento et al,
1986; Grenman et al, 1992). These findings suggest that cell cycle-
related gene(s) at the G2 checkpoint might play important roles in
the difference in radiosensitivity between these cancers, since the
G2-residing cells are normally more sensitive to irradiation.
However, alteration of G2 cell cycle regulators such as p53 is
reported to be infrequent in SGCs (Papadaki et al, 1996; Tsubochi
et al, 2000; Kiyoshima et al, 2001). Thus, it is possible that novel
G2 cell cycle regulator(s) contribute to the different radio-
sensitivity in SGCs.
14-3-3 s (also called stratifin) was first identified as a gene
expressed specifically in the differentiated squamous epithelium,
and loss of 14-3-3 s immortalised squamous epithelium (Leffers
et al, 1993). A subsequent study showed that 14-3-3 s was strongly
induced by g-irradiation and other DNA-damaging agents via a
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sp53-dependent pathway (Hermeking et al, 1997). Moreover, Chan
et al (1999) reported that 14-3-3 s-deficient cells were rapidly
killed by ionizing radiation through a process known as mitotic
catastrophe, which was associated with a failure of the cells to
sequester cyclin B/CDC2 complex from the nucleus. More recently,
it was shown that the expression of 14-3-3 s was frequently lost in
several types of cancers due to hypermethylation of the gene
(Ferguson et al, 2000; Iwata et al, 2000; Suzuki et al, 2000; Gasco
et al, 2002a,b; Osada et al, 2002). These findings indicate that 14-3-
3 s plays diverse roles not only in the radiosensitivity of the cells
but also in tumorigenesis of several cancer, including SGCs.
In this study, we investigated the expression of 14-3-3 s protein
and methylation status of 14-3-3 s gene in ACC and MEC. Then,
we report for the first time that 14-3-3 s in salivary gland ACC is
frequently downregulated due to the hypermethylation of the gene.
MATERIALS AND METHODS
Immunohistochemistry (IHC)
Salivary gland cancer tissues surgically obtained at the Tokushima
University School of Dentistry from 1982 to 2002 were routinely
fixed with formalin and embedded in paraffin. Before staining,
sections 4mm thick mounted on poly-L-lysine-coated slides were
deparaffinised with xylene and rehydrated in graded ethanol. For
the purpose of antigen retrieval, sections were incubated in Target
retrieval solution (DAKO, Carpinteria, CA, USA) at 951C for
20min. After blocking with 3% horse serum in phosphate-buffered
saline, samples were incubated at room temperature for 1h with
the goat polyclonal 14-3-3 s antibody (Santa Cruz Biotechnology,
Santa Cruz, CA, USA) diluted to 1:100 and monoclonal p53
antibody (DO-7; DAKO) diluted to 1:100 with the blocking
solution, and for the subsequent steps the avidin–biotin–
peroxidase method was performed using a Vectastain ABC kit
(Vector, Burlingame, CA, USA). We defined the cases, in which
over 25% of the cancer cells were stained for 14-3-3 s or p53, as
IHC-positive (þ). When the ratio of the positive-stained cells did
not reach 25%, or the cells were not stained for 14-3-3 s or p53, we
defined these cases as IHC-negative ( ).
Methylation-specific PCR (MSP)
The cancer nests in the five 10mm-thick paraffin sections were
dissected under the stereomicroscopy with a 24-gauge needle and
mineral oil. DNA was prepared using an EX-WAX DNA Extraction
kit (Serologicals Corporation, Norcross, GA, USA) according to the
manufacturer’s instructions. In all, 1mg of genomic DNA was
subjected to sodium bisulphite modification by a CpGenome DNA
modification kit (Serologicals Corporation), and then MSP was
performed by using a primer set that covered four CG dinucleo-
tides of 14-3-3 s DNA as described previously (Ferguson et al,
2000). For the p16
INK4A gene, PCR was performed under the same
conditions as described by Herman et al (1996). Densitometric
analysis of the data was carried out by NIH imaging software (ver.
1.63). Methylation index was calculated as follows: the density of
methylated band was divided by that of unmethylated band.
Cell lines and culture
Adenoid cystic carcinoma cell lines, ACCS and ACCY (Shirasuna
et al, 1990), were kindly provided by Drs Hiroaki Ishibashi and
Kanemitsu Shirasuna (Second Department of Oral and Maxillofa-
cial Surgery, Kyusyu University School of Dentistry). Normal
salivary gland cells (SG1 and SG2) were independently cultured
from normal human submandibular gland tissue. TYS (Yanagawa
et al, 1986) and HSG (Shirasuna et al, 1981) were salivary
adenosquamous cell carcinoma cells and neoplastic human
salivary intercalated duct cells, respectively. All the cells except
normal salivary gland cells were maintained in DMEM supple-
mented with 10% FCS, 100mgml
 1 streptomycin, and 100Uml
 1
penicillin in a humidified atmosphere of 95% air and 5% CO2 at
371C. Salivary gland cells were maintained in Keratinocyte-SFM
(Invitrogen, Carlsbad, CA, USA) and antibiotics.
PCR–single-strand conformation polymorphism (SSCP)
Exons 5–8 of the p53 gene were examined for mutations by PCR–
SSCP analysis. Genomic DNA was amplified by PCR with four sets
of primers. Primers for exon 5 were as follows: 5R, 50-
ACCCTGGGCAACCAGCCCTG-30 (sense); 5L, 50-TTTATCTGTT
CACTTGTGCCC-30 (antisense). Primers for exon 6 were 6R, 50-
CTCCCAGAGACCCCAGTTGC-30 (sense); 6L, 50-TCAGATAGC
GATGTGAGCAG-30 (anti-sense). Primers for exon 7 were 7R, 50-
CAGTGTGCAGGGTGGCAAGT-30 (sense); 7L, 50-GCCACAGGTCT
CCCCAAGGC-30 (anti-sence). Primers for exon 8 were 8R, 50-
CCACCGCTTCTTGTCCTGCT-30 (sense); 8L, 50-GACCTGATTTCC
TTACTGCC-30 (anti-sense). Each target sequence was amplified in
a2 0 ml reaction volume containing 100ng genomic DNA, 0.2mM
dNTPs, 0.5mM of each primer and 0.05Uml
 1 Advantage DNA
polymerase (BD Clontech, Palo Alto, CA, USA) using the hot-start
method. PCR amplification consisted of an initial activation step of
951C for 3min, followed by 40 cycles of 951C for 1min, 56 or 581C
for 1min, and 721C for 4min. PCR products were diluted two-fold
with formamide dye solution, denatured at 951C for 5min and
separated by electrophoresis on 12.5% polyacrylamide gels with
5% glycerol at constant temperature (141C). Gels were stained and
visualised with a Silver Staining II kit (Bio-Rad Laboratories,
Hercules, CA, USA).
RNA preparation and Northern blot analysis
Cells (ACCS, ACCY, TYS, HSG, and SG) grown in monolayers were
harvested at early confluence. After 24h, RNA isolation was
performed using TRIzol reagent (Invitrogen) according to
manufacture’s instructions. RT–PCR and Northern blotting were
carried out as described previously (Kawamata et al, 1998). The
probes consisted of a 278bp fragment of human 14-3-3 s cDNA
amplified from SG cDNA. PCR for mutation analysis of p53 mRNA
was carried out under the following conditions: 951C for 3min,
followed by 30 cycles of 941C for 1min, 621C for 45s, and 721C for
1min, and a final extension at 721C for 10min. Amplified
fragments for the p53 open reading frame were cloned by a TOPO
TA cloning system (Invitrogen), and five independent clones were
sequenced by an ALOKA DNA sequencer (ALOKA, Tokyo, Japan).
The primers used were as follows: for 14-3-3 s,5 0-GTGT
GTCCCCAGAGCCATGG-30 and 50-ACCTTCTCCCGGTACTCA
CG-30; for p53, 50-GGAATTCCGATGGAGGAGCCGCAGTCAG-30
and 50-GCGTCGACTCAGTCTGAGTCAGGCCCTTC-30.
Western blotting
Cells were seeded at a density of 1 10
5 cells per 60mm culture
dish. Next, the cells were lysed with a buffer containing 50mM
Tris-HCl (pH 7.5), 150mM NaCl, 1% Nonidet P-40, and a protease
inhibitor cocktail tablet (Roche Molecular Biochemicals, Man-
nheim, Germany). After centrifugation, aliquots of the supernatant
containing 30mg protein were analysed by 10% SDS–polyacryla-
mide gel electrophoresis. The separated proteins were transferred
to a polyvinylidene difluoride membrane (Amersham Pharmacia
Biotech., Uppsala, Sweden), and the membrane was incubated
with primary antibodies against 14-3-3 s, and b-actin (Sigma,
St Louis, MO, USA), followed by horseradish peroxidase-
conjugated secondary antibodies. Detection was then performed
using an enhanced chemiluminescence kit (Amersham Pharmacia
Biotech.).
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sSequencing analysis of 14-3-3 r gene after sodium
bisulphite treatment
Genomic DNA was prepared by the SDS–proteinase K method,
and then subjected to the sodium bisulphite modification. The
DNA modification was performed by a CpGenome DNA modifica-
tion kit (Serologicals Corporation) as described above. Bisulphite-
converted DNA was amplified, using primers that generated a
474-bp PCR product, as described previously (Ferguson et al,
2000). Amplified PCR products were cloned by using the TOPO TA
cloning system, then DNA sequencing was performed using an
ALOKA DNA sequencer. Five independent clones were sequenced
for each cell line.
Treatment of cells with 5-aza-20-deoxycytidine
Cells were seeded at a density of 2 10
6 cells 60mm plate
 1. After
24h, cells were treated with or without 5mM 5-aza-20-deoxycytidine
(Sigma) for 3 days. Preparation of total RNA, protein, and RT–
PCR were performed under the conditions as described above.
Irradiation of the cells
Logarithmically growing cells (SG1 and ACCY) were exposed to X-
ray irradiation at 15Gy (150kVp, 5mA; MBR-1505R2, Hitachi
Medico, Tokyo, Japan). After 24, 48, and 72h, the cells were
harvested, and then the cells were subjected to flow cytometric
analysis or Western blotting.
Flow cytometric analysis
After irradiation, the cells were trypsinised and fixed with 70%
cold ethanol. Then, the precipitates were incubated with propi-
dium iodide (PI) (40mgml
 1) and RNaseA (100mgml
 1) for
30min at 371C, and analysed with an EPICS flow cytometer
(Coulter, San Jose, CA, USA).
RESULTS
Expression of 14-3-3 r in SGCs
We examined the expression of 14-3-3 s in 10 cases of normal
salivary gland, 14 cases of ACC, and 10 cases of MEC. In several
SGCs occurred at minor salivary gland, we could observe the
normal gingival tissue in the surgically resected samples. We used
normal gingival tissue as positive control for IHC of 14-3-3 s.I n
normal gingival epithelial cells, 14-3-3 s was barely detectable in
the basal layer, but was increased in the suprabasal layers
(Figure 1A), as described by Dellambra et al (2000). In normal
salivary gland, we found the positive staining of 14-3-3 s protein
on the salivary duct cells and the mucous gland cells, but not in the
myoethithelial cells (Figure 1B). In ACCs, expression of 14-3-3 s
was hardly detected in the neoplastic myoepihtelial cells, but
faintly in the neoplastic duct cells (Figure 1C and D). Only in one
case of 11 ACCs, more than 20% of the cells (mainly in the
neoplastic duct cells) were positive for 14-3-3 s (Figure was not
shown, Table 1). However, in MECs, most of the cells in most of
the cases showed positive staining for 14-3-3 s (Figure 1E and F).
We summarised the result of the IHC for 14-3-3 s in Table 1.
Mutational status of p53 and the relation of the expression
pattern of 14-3-3 r with the p53 status in SGCs
14-3-3 s is also known as a cell cycle regulator of the G2 phase, and
is a target gene of the tumour suppressor p53 protein. Therefore,
mutational status of p53 in ACC and MEC was examined by IHC
and PCR–SSCP. Immunohistochemical study revealed that strong
staining of p53 protein was infrequent both in ACC (three out of
14) and MEC (two out of 10) (Figure 1G, H and Table 1). Moreover,
as shown in Table 1, PCR–SSCP revealed that the mutation rate of
the p53 gene was increased – but still relatively low – in both ACC
and MEC. There are no clear relationship between the expression
pattern of 14-3-3 s and p53 status in both ACC and MEC (Table 1).
Methylation status of 14-3-3 r gene and p16INK4A gene in
SGCs
It has been reported that downregulation of 14-3-3 s in several
cancers was due to hypermethylation of the gene. Therefore,
methylation status of the 14-3-3 s gene in ACC and MEC was
examined by Microdissection–MSP method. The 14-3-3 s gene
was frequently hypermethylated in ACC, but not in MEC
(Figure 2A). In addition, densitometric analysis revealed that the
Figure 1 Immunohistochemical detection of 14-3-3 s (A–F) and p53
(G, H). (A) Normal gingiva. (B) Normal salivary gland. (C) Adenoid cystic
carcinoma with cribriform subtype. (D) Adenoid cystic carcinoma with
solid subtype. (E, F) Mucoepidermoid carcinoma. (G) Adenoid cystic
carcinoma with negative staining of p53. (H) Adenoid cystic carcinoma with
positive staining of p53. Original magnification,  400.
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smethylation index of ACC was significantly higher than that of
MEC (one-way ANOVA, P¼0.0304; Figure 2B). We also examined
the methylation status of the p16
INK4A gene, which has been shown
to be frequently hypermethylated in several types of cancers
(Herman et al, 1996; Rocco and Sidransky, 2001), and was
coincidentally inactivated with 14-3-3 s in oral and vulval
squamous cell carcinoma (Gasco et al, 2002a,b). The methylation
of p16INK4A was less frequent than that of 14-3-3 s in ACC, but
was infrequently detected both in these cancers at the same level
(Figure 2A,B).
Expression of 14-3-3 r in cultured-human SGC cells
To confirm the result from the clinical materials, we examined the
expression of 14-3-3 s in cultured-human SGC cells. By means of
Northern (Figure 3A) and Western blotting (Figure 3B), down-
regulation of 14-3-3 s was detectable in two human ACC cell lines,
ACCS and ACCY, and a neoplastic human salivary intercalated
duct cell line, HSG, in comparison with a human salivary
adenosquamous carcinoma cell line, TYS, and primary cultured-
normal salivary gland cells, SGs.
Epigenetic change of 14-3-3 r gene in cultured-ACC cells
In order to clarify the mechanism for the downregulation of 14-3-3
s in cultured-ACC cell lines, the methylation status of 14-3-3 s
gene was assessed by the sequencing analysis after treatment with
sodium bisulphite. As shown in Figure 4A, normal salivary gland
cells, SG1, and a human adenosquamous carcinoma cell lines, TYS,
showed no methylation in 14-3-3 s gene, and a neoplastic human
salivary intercalated duct cell line, HSG, showed very limited
hemimethylation pattern in 14-3-3 s gene. However, the ACC cell
lines, ACCS and ACCY, carried widely hemimethylated 14-3-3 s
DNA (Figure 4A). In the human fibrosarcoma cell line, HT1080 we
used as positive control (Leffers et al, 1993), 14-3-3 gene was
almost completely methylated (Figure 4A). We further confirmed
the association between the methylation pattern and downregula-
tion of 14-3-3 s by using a DNA demethylating agent, 5-aza-2’-
deoxycytidine. Treatment of ACCY cells with 5-aza-20-deoxycyti-
dine at 5mM clearly upregulated the 14-3-3 s mRNA and protein
(Figure 4B,C).
Impaired G2/M arrest in ACC cells
As shown in Figure 5A and B, accumulation of the cells in the G2/
M phase and strong induction of the 14-3-3 s protein after
irradiation were observed in the normal salivary gland cells, SG1.
In contrast, irradiation did not induce the expression of 14-3-3 s
and G2/M arrest in ACCY cells, but markedly increased the cell
population at the sub-G1 peak, indicating cell death.
DISCUSSION
In this study, we examined the expression of 14-3-3 s in the most
common human SGCs, ACC and MEC. The findings obtained from
Table 1 Summary of the IHC, MSP, and PCR–SSCP
IHC Methylation index PCR–SSCP
No. Primary site 14-3-3 r p53 14-3-3 r p16 p53 (exons 5–8)
ACC1 Palate   + (N) 2.25 0.29 Exon 7
ACC2 Submandibular gland    1.40 0.31 NC
ACC3 Floor of mouth   + (N) 0.45 0.31 Exon 5
ACC4 Floor of mouth    3.26 1.75 Exon 6
ACC5 Tongue    0.59 0.14 NC
ACC6 Maxillary sinus    0.78 1.35 NC
ACC7 Palate    0.96 0.88 NC
ACC8 Sublingual gland    0.85 1.07 Exon 6
ACC9 Mandible    ND ND NC
ACC10 Floor of mouth +   ND ND NC
ACC11 Palate    ND ND ND
ACC12 Palate    ND ND ND
ACC13 Maxillary sinus    ND ND ND
ACC14 Submandbular gland    ND ND ND
Mean 1.32 0.76
Positive 1 2
MEC1 Palate +   0.72 0.24 NC
MEC2 Buccal mucosa + + (C) 0.41 0.37 Exons 5–7
a
MEC3 Buccal mucosa +   0.56 2.30 NC
MEC4 Mandible +   0.11 0.67 NC
MEC5 Palate + + (C) 0.80 0.11 Exon 6
MEC6 Palate +   0.44 0.21 NC
MEC7 Maxillary sinus +   0.41 0.27 NC
MEC8 Parotid gland +   0.34 0.25 ND
MEC9 Mandible +   ND ND ND
MEC10 Submandibular gland +   ND ND ND
Mean 0.47 0.55
Positive 10 2
 ¼negative staining; +¼positive staining; ND¼not determined; (N)¼staining in the nucleus; (C)¼staining in the cytoplasm. Methylation index was calculated as follows: the
density of methylated band was divided by that of unmethylated band. NC¼no change; ND¼not determined; IHC¼immunohistochemistry; MSP¼methylation-specific PCR;
PCR-SSCP¼PCR–single-strand conformation polymorphism.
aNot amplified.
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sthe present series of experiments are as follows. First, expression of
14-3-3 s was frequently lost in ACC, but not in MEC. Second,
downregulation of 14-3-3 s in ACC was not due to the alteration of
the p53 tumour suppressor protein, but rather to hypermethyla-
tion of the CpG islands of 14-3-3 s gene. Third, a cultured-ACC cell
line, ACCY, also showed downregulation of 14-3-3 s and
hypermethylation of the CpG islands of 14-3-3 s gene. Fourth,
14-3-3 s was not induced by irradiation in ACCY, and ACCY was
very sensitive to the irradiation. These results suggest that
downregulation of 14-3-3 s might be a critical event not only for
the development of salivary gland ACC but also for the radio-
sensitivity of ACC cells.
Salivary gland ACCs are histologically divided into three groups:
cribriform, tubular, and solid subtypes. Adenoid cystic carcinoma
with solid subtypes has shown the worst prognosis. Stallmach et al
(2002) reported that loss of heterozygosity at chromosome 6q23–
25 was frequently found in the histological solid subtype of ACC.
Yamamoto et al (1996) also demonstrated that the loss of
heterozygosity in the p53 gene was higher in the solid subtype
than in the cribriform subtype. In our present experiment,
downregulation of 14-3-3 s frequently occurred in various
subtypes of ACC, but not in MEC. In normal salivary gland, 14-
3-3 s was highly expressed in duct cells and acinic cells but faintly
in the myoepithelial cells. Mucoepidermoid carcinoma composed
of the neoplastic epidermoid cells probably originated from
precursor duct cells and of the neoplastic mucous producing cells,
but most of the ACC are predominantly composed of the
neoplastic myoepithelial cells. Thus, if the expression of 14-3-3 s
might be downregulated even in the neoplastic myoepithelial cells,
then the overall expression of 14-3-3 s in ACC was markedly
limited.
It was reported that coincident epigenetic silencing of 14-3-3 s
and p16
INK4A by methylation was an early event of carcinogenesis
in oral cancers and vulval SCC (Gasco et al, 2002a,b). Moreover,
downregulation of 14-3-3 s was reported to allow primary human
keratinocyte to escape replicative senescence accompanied by
downregulation of p16
INK4A (Dellambra et al, 2000). In our present
study, we could detect frequent hypermethylation of 14-3-3 s gene
in ACC, but not that of p16
INK4A gene. However, three ACCs
(ACC4, 6, 9), which have comparatively high methylation index of
p16
INK4A, showed histopathologically solid subtypes. Interestingly,
Shintani et al (2000) have reported that p16
INK4A absent cases were
the tumours with predominantly solid pattern by means of
immunohistochemistry. Thus, in salivary gland ACC, downregula-
tion of p16
INK4A might be critical event for the acquisition of
histological subtype of ACC, and epigenetic silencing of 14-3-3 s
was also considered to be an early event of carcinogenesis. Then,
the genetic changes, such as p53 mutation, may occur in the
ACC
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Figure 2 Methylation-specific PCR of the CpG island of the 14-3-3 s
and p16
INK4A genes in ACC and MEC. (A) Microdissected tissues were
subjected to MSP, and electrophoresis was performed in 4% agarose gels.
The human fibrosarcoma cell line HT1080 was used as a positive control
for methylated 14-3-3 s. Normal salivary gland cells (SG) treated with SssI
methyltransferase were used as a positive control for p16
INK4A. Water was
used as a negative control. (B) Methylation of the 14-3-3 s and p16
INK4A
genes was semiquantitated by densitometric analysis. Methylation indices
were calculated by dividing the density of the unmethylated allele into that
of the methylated allele. Horizontal bars and vertical bars show mean and
s.d., respectively. *Statistically significant by one-way ANOVA
(*P¼0.0304).
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Figure 3 Expression of 14-3-3 s in human SGC cells. (A) Detection of
14-3-3 s mRNA by Northern blot analysis. (B) Detection of 14-3-3 s
protein by Western blot analysis.
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ssubsequent step on the salivary gland carcinogenesis. Osada et al
(2002) demonstrated that small-cell lung cancer cell lines
frequently showed DNA hypermethylation of 14-3-3 s, but non-
small-cell lung cancer cell lines did not. In our experiment,
methylation pattern was quite different in the histological subtypes
of SGCs, ACC, and MEC. Thus, methylation pattern of 14-3-3 s
gene was highly affected by the originated cell type in the tumour.
14-3-3 s is known to be one of the target genes of the tumour
suppressor p53 protein. Alterations in the p53 gene have been
frequently observed in various human carcinomas (Hollstein et al,
1991), and are considered to be one of the most critical genetic
changes in the process of carcinogenesis. However, unlike other
carcinomas reported previously, ACC and MEC showed relatively
low rates of alteration of p53 in the present study. Kiyoshima et al
(2001) and Papadaki et al (1996) also reported low frequency of the
alteration of p53 gene in ACC and MEC. Thus, the downregulation
of 14-3-3 s in ACC might not be due to the inactivation of p53
pathway, and inactivation of 14-3-3 s by methylation may lead to
impairment of some of the functions of p53 as a ‘gatekeeper’.
Meanwhile, as shown in Table 1 and Figure 2, ACC3 showed
downregulation of the 14-3-3 s protein, but no methylation of the
gene was detectable. However, if ACC3 showed mutation in p53
gene (Table 1), then downregulation of 14-3-3 s in ACC3 might be
affected by the mutated p53.
Although most of ACC tissue simultaneously showed high
methylation index of 14-3-3 s gene and downregulation of 14-3-3 s
protein, some cases did not show the correlation between the
methylation index and expression level of 14-3-3 s. The reason for
this discrepancy was unclear at present, however, it might be due
to contamination of the stromal cells for analysis or the presence of
another pre- or post-transcriptional regulation of 14-3-3 s.
Recently, Urano et al (2002) demonstrated that Efp, a RING-
finger-dependent ubiquitin ligase (E3) targeted proteolysis of 14-3-
3 s. In SGC cells, proteolysis of 14-3-3 s by ubiquitin–proteasome
pathway might contribute to regulate the level of 14-3-3 s protein.
Using cultured-SGC cells, we found the downregulation of 14-3-
3 s in ACC cell lines with hemimethylation of the 14-3-3 s gene,
but mutational analysis showed that ACCY cells carried the mutant
type p53 at Tyr126Stop (data not shown). Therefore, the down-
regulation of 14-3-3 s in ACCY cell lines was caused by the
hemimethylation of 14-3-3 s gene and by the dysfunction of p53
pathway. Normal salivary gland cells, SG1, carried wild-type p53
gene, and showed nonmethylation pattern of 14-3-3 s gene and
high expression of 14-3-3 s mRNA and protein. DNA damage
induced by the irradiation enhanced the expression of 14-3-3 s
protein in SG1 cells. These results indicated that expression of 14-
3-3 s in normal salivary gland cells was regulated by the activated
p53 on the nonmethylated 14-3-3 s gene. HSG and TYS cells that
were reported to carry mutant type p53 at Asn30Ser and
Asp281His, respectively (Shinagawa et al, 2003). HSG and TYS
cells showed different expression patterns of 14-3-3 s. Shinagawa
et al (2003) also reported that DNA-damaging chemotherapeutic
drugs did not activate any reporter plasmids containing the
promoter sequence of p53 target genes (p21waf1, BAX, MDM2,
p53AIP1,o rPUMA) in HSG cells, but activated only the p21waf1
promoter in TYS cells. Thus, mutated p53 in TYS cells, but not the
mutated p53 in HSG cells, might affect the expression of 14-3-3 s.
The 14-3-3 s gene has been reported to be a G2 checkpoint
control gene. Since 14-3-3 s ( / ) cells are defective in their
maintenance of G2 arrest, they enter M phase without repair of the
aberrant chromosome structures and undergo cell death during
mitosis (Chan et al, 1999). In the present experiment, apparent G2/
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Figure 4 Methylation status of the 14-3-3 s gene in human SGC cells.
(A) Sodium bisulphite sequencing of the 14-3-3 s CpG island. The
methylated CpG sites are indicated by solid circles, and the unmethylated
CpG sites are indicated by open circles. The cell lines examined are shown
on the left. (B) Reactivation of 14-3-3 s mRNA in ACCY cells by
treatment with 5-aza-20-deoxycytidine for 3 days. RT–PCR was performed
by use of specific primers for 14-3-3 s. The 28S ribosomal RNA are shown
below. (C) Reactivation of 14-3-3 s protein in ACCY cells by treatment
with 5-aza-20-deoxycytidine for 5 days. Western blotting was performed by
use of specific antibodies for 14-3-3 s and actin.
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Figure 5 Cell cycle analysis of the SGC and normal cells after irradiation.
(A) Cells were irradiated at 15Gy, then harvested at 24, 48, and 72h after
irradiation. After staining with PI, cell cycles were analysed by flow
cytometry. The populations of each phase are shown for the SG1 cells (left)
and ACC cells (right). (B) Expression of the 14-3-3 s protein after
irradiation.
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sM arrest was induced in normal salivary gland cells by irradiation;
however, G2/M arrest was not induced by irradiation in the ACCY
cells. Moreover, 14-3-3 s was induced in normal salivary glands by
irradiation, while 14-3-3 s was not induced in ACCY cells.
Although the affect of factors other than 14-3-3 s could be
considered, this fragility to the irradiation in ACC cells is in
agreement with the clinical observations described previously
(Simpson et al, 1984; Vikram et al, 1984; Miglianico et al, 1987;
Garden et al, 1995; Parsons et al, 1996). These results indicate that
DNA-damaging therapy might be more effective in cancers, such
as ACC, with hypermethylation of 14-3-3 s gene than in cancers,
such as MEC, without hypermethylation of 14-3-3 s gene.
In conclusion, our findings, that 14-3-3 s is frequently down-
regulated in ACC, provide a new possible mechanism in under-
standing the mechanism of salivary gland carcinogenesis.
Furthermore, our results also indicate that DNA-damaging therapy
might be effective in SGCs with hypermethylation of 14-3-3 s gene.
Downregulation of 14-3-3 s could be useful as a predictive marker
for the radiosensitivity of SGC, and the combination of 14-3-3 s
blockade and radiotherapy could constitute a new therapeutic
approach for radioresistant SGC, particularly for MEC.
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